Explanation by the board of directors of Jiangsu Dongxing Smart Medical Technology Co., Ltd. that this transaction complies with Article 4 of the 'Regulatory Guidelines No. 9 for Listed Companies - Regulatory Requirements for Planning and Implementing Major Asset Restructuring.'